中华生物医学工程杂志
中華生物醫學工程雜誌
중화생물의학공정잡지
CHINESE JOURNAL OF BIOMEDICAL ENGINEERING
2011年
3期
269-272
,共4页
赵静%谢传淼%李建鹏%伍尧泮%王洪瑛%吴沛宏
趙靜%謝傳淼%李建鵬%伍堯泮%王洪瑛%吳沛宏
조정%사전묘%리건붕%오요반%왕홍영%오패굉
促纤维组织增生性小圆细胞瘤%体层摄影术,X线计算机%药物疗法,联合%腹部肿瘤%盆腔肿瘤
促纖維組織增生性小圓細胞瘤%體層攝影術,X線計算機%藥物療法,聯閤%腹部腫瘤%盆腔腫瘤
촉섬유조직증생성소원세포류%체층섭영술,X선계산궤%약물요법,연합%복부종류%분강종류
Desmoplastic small round cell tumor%Tomography,X-ray computed%Drug therapy,combination%Abdominal neoplasms%Pelvic neoplasms
观察分析腹、盆腔促纤维组织增生性小圆细胞瘤(DSRCT)的CT表现特征及其化疗疗效。方法 回顾性分析2006年11月至2009年12月本院诊治的经病理证实的3例腹、盆腔DSRCT患者的CT影像表现,采用鬼臼乙叉甙(VP-16)+异环磷酰胺(IFO)+顺铂(DDP)或IFO+表阿霉素(EPI)化疗方案进行化疗,21 d为1个周期,其中病例1化疗2个周期、病例2化疗6个周期、病例3化疗4个周期。根据化疗前后最近两次的CT影像诊断,应用实体瘤疗效评价标准(RECIST)评价疗效。结果 CT显示DSRCT较典型的表现为腹、盆腔单发巨大或多发不规则结节或软组织肿块,与网膜、系膜及腹膜关系密切,原发位置较难确定;肿块密度多不均匀,内常见低密度坏死区,并可见斑点或片状钙化,增强后肿块轻~中等不均匀强化;较早出现淋巴结转移,晚期较常见肝、肺转移;晚期当肿块较大时,可压迫或侵犯邻近输尿管或肠管,引起肾积水或肠梗阻。多疗程联合化疗后3例患者均病情部分缓解(PR)。结论 DSRCT具有相对特征性的CT影像表现,多疗程联合化疗可控制病情发展。
觀察分析腹、盆腔促纖維組織增生性小圓細胞瘤(DSRCT)的CT錶現特徵及其化療療效。方法 迴顧性分析2006年11月至2009年12月本院診治的經病理證實的3例腹、盆腔DSRCT患者的CT影像錶現,採用鬼臼乙扠甙(VP-16)+異環燐酰胺(IFO)+順鉑(DDP)或IFO+錶阿黴素(EPI)化療方案進行化療,21 d為1箇週期,其中病例1化療2箇週期、病例2化療6箇週期、病例3化療4箇週期。根據化療前後最近兩次的CT影像診斷,應用實體瘤療效評價標準(RECIST)評價療效。結果 CT顯示DSRCT較典型的錶現為腹、盆腔單髮巨大或多髮不規則結節或軟組織腫塊,與網膜、繫膜及腹膜關繫密切,原髮位置較難確定;腫塊密度多不均勻,內常見低密度壞死區,併可見斑點或片狀鈣化,增彊後腫塊輕~中等不均勻彊化;較早齣現淋巴結轉移,晚期較常見肝、肺轉移;晚期噹腫塊較大時,可壓迫或侵犯鄰近輸尿管或腸管,引起腎積水或腸梗阻。多療程聯閤化療後3例患者均病情部分緩解(PR)。結論 DSRCT具有相對特徵性的CT影像錶現,多療程聯閤化療可控製病情髮展。
관찰분석복、분강촉섬유조직증생성소원세포류(DSRCT)적CT표현특정급기화료료효。방법 회고성분석2006년11월지2009년12월본원진치적경병리증실적3례복、분강DSRCT환자적CT영상표현,채용귀구을차대(VP-16)+이배린선알(IFO)+순박(DDP)혹IFO+표아매소(EPI)화료방안진행화료,21 d위1개주기,기중병례1화료2개주기、병례2화료6개주기、병례3화료4개주기。근거화료전후최근량차적CT영상진단,응용실체류료효평개표준(RECIST)평개료효。결과 CT현시DSRCT교전형적표현위복、분강단발거대혹다발불규칙결절혹연조직종괴,여망막、계막급복막관계밀절,원발위치교난학정;종괴밀도다불균균,내상견저밀도배사구,병가견반점혹편상개화,증강후종괴경~중등불균균강화;교조출현림파결전이,만기교상견간、폐전이;만기당종괴교대시,가압박혹침범린근수뇨관혹장관,인기신적수혹장경조。다료정연합화료후3례환자균병정부분완해(PR)。결론 DSRCT구유상대특정성적CT영상표현,다료정연합화료가공제병정발전。
Objective To investigate and analyze the CT features and chemotherapy efficacy of desmoplastic small round cell tumors (DSRCTs) in abdomen and pelvis. Methods Between November 2006 and December 2009, the CT images of 3 patients with pathology-confirmed DSRCTs in abdomen or pelvis in our hospital were retrospectively analyzed. The protocol of chemotherapy was epiopodophyllotoxin (VP-16)+ isofosfamide(IFO)+ cisplatin(DDP) or IFO+epirubicin (EPI), with 21 days as one cycle. Two cycles of chemotherapy were given to case 1, 6 to case 2, and 4 to case 3. The efficacy of chemotherapy was then evaluated using the response evaluation criteria in solid tumors (RECIST) according to two immediately consecutive CT scans performed respectively before and after chemotherapy. Results The CT showed that DSRCTs were typically featured by single large or multiple irregular nodules or soft masses in abdomen and pelvis. These lesions were in close anatomic relation with the omentum, mesenterium or peritoneum, whereas the primary lesion appeared difficult to identify. The masses were mostly uneven in density, usually with lowdensity necrotic regions inside, and spotty or patchy calcification as well. After use of contrast agent, mild to moderate heterogeneous enhancement was found in the masses. Lymph node metastasis could be present in the early stage, while the liver and lung metastasis were commonly seen in the advanced stage. Larger latestage lesions may compress or invade the adjacent urinary tracts or intestines to cause hydronephrosis or intestinal obstruction. Partial remission (PR) was achieved in the three cases after several courses of combined chemotherapy. ConclusionsDSRCT may show typical features on CT images. Multi-course combined chemotherapy may help control the disease progression.